The drug from COVID-19 "Cornavin" has been approved by the Ministry of health. It was developed by the company " R-Pharm ".
This is the third Medicine approved by the Russian with the "Avifauna" (production of RDIF and Chemrar ) and "Kalivia" company " Promomed ".
"Cornavin" can only be used in a hospital environment. Tool should not be used during pregnancy and its planning, in the period of breastfeeding, and people with severe renal and hepatic insufficiency. The drug is also contraindicated to persons under 18 years of age.
Medicine registered under the procedure provided in the conditions of risk of disaster and destruction. So, the instruction is written with a limited amount of clinical data and will be supplemented as new information becomes available.
In addition to " Coronavirus ", "R-farm" together with the RDIF create an enterprise with total investment more than 4 billion to deal with the new infection. For example, it will be expanding the release of olokizumab, solution complications COVID-19, and vaccine manufacturing.
before the world health organization became interested in the " Aviation ". In addition, the who are waiting for the production of the Russian vaccine.
The main scientific employee of the organization Sumia Swaminathan recalled that the who is the "Tests of solidarity" aimed at the exchange of data on drugs and vaccines against coronavirus. She also expressed hope that Russian scientists will agree on the interaction.
currently, Russia is in the "test of solidarity" is not involved. The program also failed to connect USA, UK, China and France.
Current information on the situation of COVID-19 in Russia and the world presented on the portal stopmanager. Of the Russian Federation.